Background-The mechanism of delayed preconditioning induced by activation o
f adenosine A(1) receptors (A(1)ARs) is not fully understood. We determined
the role of inducible nitric oxide synthase (iNOS) in mediating adenosine-
induced late cardioprotection using pharmacological inhibitors and iNOS gen
e-knockout mice.
Methods and Results-Adult male mice were treated with saline or an A,AR ago
nist, 2-chloro-N-6-cyclopentyladenosine (CCPA). Twenty-four hours later, th
e hearts were perfused in Langendorff mode and subjected to 30 minutes of g
lobal ischemia followed by 30 minutes of reperfusion. 8-Cyclopentyl-1,3-dip
ropylxanthine (DPCPX; 0.1 mg/kg IP) and S-methylisothiourea (SMT; 3 mg/kg I
P) were used to block A(1)ARs and iNOS, respectively. Infarct size (IS) was
measured by triphenyltetrazolium chloride staining, and iNOS expression wa
s measured by Western blots. Myocardial IS was reduced from 24.0+/-3.2% in
the saline group to 12.2+/-2.5% in CCPA-treated mice (P<0.05). The infarct-
reducing effect of CCPA was abrogated by DPCPX (29.3 +/- 3.4%) and SMT (32.
3 +/- 2.6%) and was absent in mice with targeted ablation of iNOS (23.9+/-1
.6%). CCPA produced improvement in postischemic end-diastolic pressure, dev
eloped pressure, and rate-pressure product, which was also blocked by DPCPX
and SMT. Increased iNOS protein expression observed in CCPA-treated hearts
was diminished by DPCPX.
Conclusions-Selective activation of A(1)ARs produces delayed cardioprotecti
on against ischemia/reperfusion injury in the mouse. Increased iNOS express
ion concomitant with the lack of protective effect of A(1)AR activation in
iNOS gene-knockout mice suggests a direct cause-and-effect relationship of
iNOS in adenosine-induced late cardioprotection.